# ESTEE LAUDER COMPANIES INC (EL)

Informational only - not investment advice.

CIK: 0001001250
SIC: 2844 Perfumes, Cosmetics & Other Toilet Preparations
SIC breadcrumb: [Manufacturing](/division/D/) > [Chemicals And Allied Products](/major-group/28/) > [SIC 2844 Perfumes, Cosmetics & Other Toilet Preparations](/industry/2844/)
Latest 10-K filed: 2025-08-20
SEC page: https://www.sec.gov/edgar/browse/?CIK=1001250
Filing source: https://www.sec.gov/Archives/edgar/data/1001250/000100125025000099/el-20250630.htm

## At a glance

FY2025 · period end 2025-06-30 · filed 2025-08-20 · accession 0001001250-25-000099 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001001250.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 14,326,000,000 USD | 2025 | verified |
| Net income | -1,133,000,000 USD | 2025 | verified |
| Assets | 19,892,000,000 USD | 2025 | verified |
| Free cash flow | 670,000,000 USD | 2025 | computed |
| Net margin | -7.91% | 2025 | computed |
| Operating margin | -5.48% | 2025 | computed |
| Revenue YoY | -8.21% | 2025 | computed |
| ROE | -29.31% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | EL | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | -7.9% | 1.6% | 0 | 9 |
| Operating margin | -5.5% | 4.3% | 0 | 9 |
| Revenue growth | -8.2% | 0.1% | 0 | 9 |
| FCF margin | 4.7% | 11.4% | 25 | 9 |
| ROE | -29.3% | 2.0% | 0 | 8 |
| ROA | -5.7% | 1.1% | 0 | 9 |
| Liabilities / equity | 4.15 | 1.52 | 88 | 9 |
| Current ratio | 1.30 | 1.76 | 38 | 9 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 2844 Perfumes, Cosmetics & Other Toilet Preparations, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 14326000000 | USD | 2025 | 2025-08-20 |
| Net income | -1133000000 | USD | 2025 | 2025-08-20 |
| Assets | 19892000000 | USD | 2025 | 2025-08-20 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2025-08-20. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001001250.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue |  | 11,824,000,000 | 13,683,000,000 | 14,863,000,000 | 14,294,000,000 | 16,215,000,000 | 17,737,000,000 | 15,910,000,000 | 15,608,000,000 | 14,326,000,000 |
| Net income | 1,121,000,000 | 1,256,000,000 | 1,117,000,000 | 1,794,000,000 | 696,000,000 | 2,875,000,000 | 2,408,000,000 | 1,010,000,000 | 409,000,000 | -1,133,000,000 |
| Operating income | 1,610,000,000 | 1,704,000,000 | 2,055,000,000 | 2,313,000,000 | 606,000,000 | 2,618,000,000 | 3,170,000,000 | 1,509,000,000 | 970,000,000 | -785,000,000 |
| Gross profit | 9,081,000,000 | 9,390,000,000 | 10,839,000,000 | 11,476,000,000 | 10,742,000,000 | 12,381,000,000 | 13,432,000,000 | 11,346,000,000 | 11,184,000,000 | 10,597,000,000 |
| Diluted EPS | 2.96 | 3.35 | 2.95 | 4.82 | 1.86 | 7.79 | 6.55 | 2.79 | 1.08 | -3.15 |
| Operating cash flow | 1,789,000,000 | 1,790,000,000 | 2,562,000,000 | 2,517,000,000 | 2,280,000,000 | 3,631,000,000 | 3,040,000,000 | 1,731,000,000 | 2,360,000,000 | 1,272,000,000 |
| Capital expenditures | 525,000,000 | 504,000,000 | 629,000,000 | 744,000,000 | 623,000,000 | 637,000,000 | 1,040,000,000 | 1,003,000,000 | 919,000,000 | 602,000,000 |
| Dividends paid | 423,000,000 | 486,000,000 | 546,000,000 | 609,000,000 | 503,000,000 | 753,000,000 | 840,000,000 | 925,000,000 | 947,000,000 | 618,000,000 |
| Share buybacks | 890,000,000 | 413,000,000 | 759,000,000 | 1,555,000,000 | 893,000,000 | 733,000,000 | 2,309,000,000 | 271,000,000 | 35,000,000 | 35,000,000 |
| Assets | 9,223,000,000 | 11,568,000,000 | 12,567,000,000 | 13,156,000,000 | 17,781,000,000 | 21,971,000,000 | 20,910,000,000 | 23,415,000,000 | 21,677,000,000 | 19,892,000,000 |
| Stockholders' equity | 3,587,000,000 | 4,402,000,000 | 4,710,000,000 | 4,411,000,000 | 3,962,000,000 | 6,091,000,000 | 5,590,000,000 | 5,585,000,000 | 5,314,000,000 | 3,865,000,000 |
| Free cash flow | 1,264,000,000 | 1,286,000,000 | 1,933,000,000 | 1,773,000,000 | 1,657,000,000 | 2,994,000,000 | 2,000,000,000 | 728,000,000 | 1,441,000,000 | 670,000,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin |  | 10.62% | 8.16% | 12.07% | 4.87% | 17.73% | 13.58% | 6.35% | 2.62% | -7.91% |
| Operating margin |  | 14.41% | 15.02% | 15.56% | 4.24% | 16.15% | 17.87% | 9.48% | 6.21% | -5.48% |
| Return on equity | 31.25% | 28.53% | 23.72% | 40.67% | 17.57% | 47.20% | 43.08% | 18.08% | 7.70% | -29.31% |
| Return on assets | 12.15% | 10.86% | 8.89% | 13.64% | 3.91% | 13.09% | 11.52% | 4.31% | 1.89% | -5.70% |
| Liabilities / equity | 1.57 | 1.63 | 1.67 | 1.98 | 3.49 | 2.61 | 2.74 | 3.19 | 3.08 | 4.15 |
| Current ratio | 1.58 | 1.76 | 1.86 | 1.57 | 1.72 | 1.84 | 1.60 | 1.46 | 1.39 | 1.30 |

## As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-01. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001001250.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2023-Q1 | 2022-09-30 |  |  | 1.35 | reported discrete quarter |
| 2023-Q2 | 2022-12-31 |  |  | 1.09 | reported discrete quarter |
| 2023-Q3 | 2023-03-31 |  |  | 0.43 | reported discrete quarter |
| 2023-Q4 | 2023-06-30 | 3,609,000,000 | -33,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2023-09-30 | 3,518,000,000 | 31,000,000 | 0.09 | reported discrete quarter |
| 2024-Q2 | 2023-12-31 | 4,279,000,000 | 313,000,000 | 0.87 | reported discrete quarter |
| 2024-Q3 | 2024-03-31 | 3,940,000,000 | 330,000,000 | 0.91 | reported discrete quarter |
| 2024-Q4 | 2024-06-30 | 3,871,000,000 | -284,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2024-09-30 | 3,361,000,000 | -156,000,000 | -0.43 | reported discrete quarter |
| 2025-Q2 | 2024-12-31 | 4,004,000,000 | -590,000,000 | -1.64 | reported discrete quarter |
| 2025-Q3 | 2025-03-31 | 3,550,000,000 | 159,000,000 | 0.44 | reported discrete quarter |
| 2025-Q4 | 2025-06-30 | 3,411,000,000 | -546,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2025-09-30 | 3,481,000,000 | 47,000,000 | 0.13 | reported discrete quarter |
| 2026-Q2 | 2025-12-31 | 4,229,000,000 | 162,000,000 | 0.44 | reported discrete quarter |
| 2026-Q3 | 2026-03-31 | 3,712,000,000 | 89,000,000 | 0.24 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from EL's latest 10-K: [/company/EL/business/](/company/EL/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from EL's latest 10-K: [/company/EL/risk-factors/](/company/EL/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-20260331.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary.
Confidence: high
Filing date: 2026-05-01
Report date: 2026-03-31

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

RESULTS OF OPERATIONS

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. We are a steward of over 20 luxury and prestige brands globally. Our products are sold in approximately 150 countries and territories. We operate as a wholesaler, with our products sold in brick-and-mortar locations and on various e-commerce platforms, including those operated by department stores, duty-free retailers, specialty-multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas. Additionally, we operate a direct-to-consumer business across freestanding stores, our brands' websites and third-party online platforms.

[[GREPCENT_TABLE]]
[["","","Three Months Ended March 31,","","Nine Months Ended March 31,"],["","","2026","","2025","","2026","","2025"],["($ in millions)","","$","","%","","$","","%","","$","","%","","$","","%"],["Net sales","","$","3,712","","","100.0","%","","$","3,550","","","100.0","%","","$","11,422","","","100.0","%","","$","10,915","","","100.0","%"],["Cost of sales","","876","","","23.6","","","889","","","25.0","","","2,797","","","24.5","","","2,774","","","25.4"],["Gross profit","","2,836","","","76.4","","","2,661","","","75.0","","","8,625","","","75.5","","","8,141","","","74.6"],["Operating expenses:"],["Selling, general and administrative","","2,279","","","61.4","","","2,258","","","63.6","","","7,202","","","63.1","","","7,141","","","65.4"],["Restructuring and other charges","","224","","","6.0","","","97","","","2.7","","","520","","","4.6","","","375","","","3.4"],["Securities class action litigation settlement","","84","","","2.3","","","\u2014","","","\u2014","","","84","","","0.7","","","\u2014","","","\u2014"],["Impairment of goodwill and other intangible assets","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","861","","","7.9"],["Talcum litigation settlement agreements","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","\u2014","","","159","","","1.5"],["Total operating expenses","","2,587","","","69.7","","","2,355","","","66.3","","","7,806","","","68.3","","","8,536","","","78.2"],["Operating income (loss)","","249","","","6.7","","","306","","","8.6","","","819","","","7.2","","","(395)","","","(3.6)"],["Interest expense","","82","","","2.2","","","87","","","2.5","","","253","","","2.2","","","269","","","2.5"],["Interest income and investment income, net","","15","","","0.4","","","27","","","0.8","","","66","","","0.6","","","85","","","0.8"],["Other components of net periodic benefit cost","","3","","","0.1","","","5","","","0.1","","","11","","","0.1","","","10","","","0.1"],["Earnings (loss) before income taxes","","179","","","4.8","","","241","","","6.8","","","621","","","5.4","","","(589)","","","(5.4)"],["Provision (benefit) for income taxes","","90","","","2.4","","","82","","","2.3","","","323","","","2.8","","","(2)","","","\u2014"],["Net earnings (loss)","","$","89","","","2.4","%","","$","159","","","4.5","%","","$","298","","","2.6","%","","$","(587)","","","(5.4)","%"]]
[[/GREPCENT_TABLE]]

Percentages not adjusted for differences caused by rounding

The following table is a comparative summary of operating results for the three and nine months ended March 31, 2026 and 2025, for our product categories and geographic regions and reflects the basis of presentation described in Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies and Note 13 – Segment Data and Related Information, for our product categories that meet the definition of reportable segments, for all periods presented. Royalty revenue from license arrangements, and products and services that do not fit within our definitions of skin care, makeup, fragrance and hair care have been included in the “other” category.

40

Table of Contents

THE ESTÉE LAUDER COMPANIES INC.

[[GREPCENT_TABLE]]
[["","","Three Months Ended March 31,","","Nine Months Ended March 31,"],["(In millions)","","2026","","2025","","2026","","2025"],["NET SALES"],["By Product Category:"],["Skin Care","","$","1,856","","","$","1,807","","","$","5,485","","","$","5,257"],["Makeup","","1,072","","","1,035","","","3,266","","","3,223"],["Fragrance","","628","","","557","","","2,161","","","1,931"],["Hair Care","","128","","","126","","","425","","","424"],["Other","","28","","","25","","","84","","","80"],["","","3,712","","","3,550","","","11,421","","","10,915"],["Returns associated with restructuring and other activities","","\u2014","","","\u2014","","","1","","","\u2014"],["Net sales","","$","3,712","","","$","3,550","","","$","11,422","","","$","10,915"],["By Geographic Region(1):"],["The Americas","","$","1,076","","","$","1,063","","","$","3,468","","","$","3,469"],["Europe, United Kingdom and Ireland and Emerging Markets (\"EUKEM\")","","859","","","785","","","2,943","","","2,738"],["Asia/Pacific","","1,003","","","1,006","","","2,776","","","2,700"],["Mainland China","","774","","","696","","","2,234","","","2,008"],["","","3,712","","","3,550","","","11,421","","","10,915"],["Returns associated with restructuring and other activities","","\u2014","","","\u2014","","","1","","","\u2014"],["Net sales","","$","3,712","","","$","3,550","","","$","11,422","","","$","10,915"],["OPERATING INCOME (LOSS)"],["By Product Category:"],["Skin Care","","$","444","","","$","361","","","$","1,085","","","$","784"],["Makeup","","(3)","","","14","","","\u2014","","","(382)"],["Fragrance","","21","","","32","","","212","","","(354)"],["Hair Care","","(5)","","","(13)","","","1","","","(34)"],["Other","","16","","","9","","","38","","","(25)"],["","","473","","","403","","","1,336","","","(11)"],["Charges associated with restructuring and other activities","","(224)","","","(97)","","","(517)","","","(384)"],["Operating income (loss)","","$","249","","","$","306","","","$","819","","","$","(395)"],["By Geographic Region(1):"],["The Americas","","$","21","","","$","67","","","$","212","","","$","(789)"],["EUKEM","","32","","","28","","","194","","","183"],["Asia/Pacific","","261","","","232","","","611","","","460"],["Mainland China","","159","","","76","","","319","","","135"],["","","473","","","403","","","1,336","","","(11)"],["Charges associated with restructuring and other activities","","(224)","","","(97)","","","(517)","","","(384)"],["Operating income (loss)","","$","249","","","$","306","","","$","819","","","$","(395)"]]
[[/GREPCENT_TABLE]]

(1) The net sales and operating results from our travel retail business are included in the Asia/Pacific region.

Period-over-period changes in our net sales are generally attributable to the impacts from (i) pricing on our base portfolio, including changes in mix and those due to strategic pricing actions, (ii) volume, including changes driven by the impact of new product innovation, (iii) acquisitions and/or divestitures, and/or (iv) foreign currency translation. The percentages disclosed for these impacts are calculated on an individual basis.

The net sales impact from pricing consists of changes in list prices, due to strategic pricing actions, and mix shifts within and among product categories, geographic regions, brands and distribution channels. The prices at which we sell our products vary by brand, distribution channel (e.g., wholesale or direct-to-consumer) and may also vary by country. Our brands and products cover a broad array of pricing tiers. Prices of skin care and fragrance products are typically higher than makeup and hair care products.

41

Table of Contents

THE ESTÉE LAUDER COMPANIES INC.

New product innovation includes the introduction of new products, as well as changes related to existing products or where they are sold, including reformulations, regional expansion, repackaging and sets. A product is considered "new innovation" for the twelve-month period following the initial shipment date. Our innovation is launched at different price points than existing products and value derived from innovation may vary from year to year. We continually introduce new products, support new and established products through advertising, merchandising and sampling and phase out existing products that no longer meet the needs of our consumers or our objectives. The economics of developing, producing, launching, supporting and discontinuing products impact our sales and operating performance each period. The introduction of new products often has some cannibalizing effect on sales of existing products, inclusive of potential sales returns, which we take into account in our business planning. The impact of new product introductions, including timing compared to introductions in prior periods, also affects our results.

Non-GAAP Financial Measures

We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period to period helps investors and others compare operating performance between periods. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. See Reconciliations of Non-GAAP Financial Measures beginning on page 57 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.

We operate on a global basis, with the majority of our net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates affect our results of operations. Therefore, we present certain net sales, operating results and diluted net earnings (loss) per common share information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of our underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current-period results using prior-year monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.

Outlook

While we have seen improvements within our business, we are mindful of areas of volatility and uncertainty that may impact our results. We continue to face challenges in key markets in the West, including in some markets in Western Europe and the United States. Within our Asia travel retail business, we continue to experience a transitory headwind from the change of duty-free retailers servicing the Beijing and Shanghai airports, including the related online businesses. We are also monitoring the conflict in the Middle East as it relates to our business in the domestic markets and travel retail locations in the region. Net sales from locations impacted by the conflict in the Middle East accounted for approximately 2% of consolidated net sales in fiscal 2025. We continue to monitor and assess the impact that these challenges may have on net sales and profitability, including impacts to our effective tax rate from changes to our geographical mix of earnings.

We are continuing to monitor and assess the potential effects of changing tariff conditions in the United States as well as in other markets in which we operate. These tariffs have led to significant volatility and uncertainty in global markets and difficulty in forecasting demand. We have implemented and are continuing to implement and consider additional mitigation measures. Our strategy remai

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1001250/000100125025000099/el-20250630.htm
Complete FY 2025 MD&A: /company/EL/mda/fy2025/

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary.
Confidence: high
Filing date: 2025-08-20
Report date: 2025-06-30

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

RESULTS OF OPERATIONS

We manufacture, market and sell beauty products including those in the skin care, makeup, fragrance and hair care categories, which are distributed in approximately 150 countries and territories. 

[[GREPCENT_TABLE]]
[["","","Year Ended June 30,"],["","","2025","","2024","","2023"],["($ in millions)","","$","","%","","$","","%","","$","","%"],["Net sales","","$","14,326","","","100.0","%","","$","15,608","","","100.0","%","","$","15,910","","","100.0","%"],["Cost of sales","","3,729","","","26.0","","","4,424","","","28.3","","","4,564","","","28.7"],["Gross profit","","10,597","","","74.0","","","11,184","","","71.7","","","11,346","","","71.3"],["Operating expenses:"],["Selling, general and administrative","","9,456","","","66.0","","","9,621","","","61.6","","","9,575","","","60.2"],["Restructuring and other charges","","481","","","3.4","","","122","","","0.8","","","55","","","0.3"],["Goodwill impairment","","13","","","0.1","","","291","","","1.9","","","\u2014","","","\u2014"],["Impairment of other intangible assets","","1,273","","","8.9","","","180","","","1.2","","","207","","","1.3"],["Talcum litigation settlement agreements","","159","","","1.1","","","\u2014","","","\u2014","","","\u2014","","","\u2014"],["Total operating expenses","","11,382","","","79.4","","","10,214","","","65.4","","","9,837","","","61.8"],["Operating (loss) income","","(785)","","","(5.5)","","","970","","","6.2","","","1,509","","","9.5"],["Interest expense","","357","","","2.5","","","378","","","2.4","","","255","","","1.6"],["Interest income and investment income, net","","114","","","0.8","","","167","","","1.1","","","131","","","0.8"],["Other components of net periodic benefit cost","","12","","","0.1","","","(13)","","","(0.1)","","","(12)","","","(0.1)"],["(Loss) earnings before income taxes","","(1,040)","","","(7.3)","","","772","","","4.9","","","1,397","","","8.8"],["Provision for income taxes","","93","","","0.6","","","363","","","2.3","","","387","","","2.4"],["Net (loss) earnings","","(1,133)","","","(7.9)","","","409","","","2.6","","","1,010","","","6.3"],["Net earnings attributable to redeemable noncontrolling interest","","\u2014","","","\u2014","","","(19)","","","(0.1)","","","(4)","","","\u2014"],["Net (loss) earnings attributable to The Est\u00e9e Lauder Companies Inc.","","$","(1,133)","","","(7.9)","%","","$","390","","","2.5","%","","$","1,006","","","6.3","%"],["Percentages not adjusted for differences caused by rounding"]]
[[/GREPCENT_TABLE]]

29

Table of Contents

The following table is a comparative summary of operating results for fiscal 2025, 2024 and 2023, for our product categories and geographic regions and reflects the basis of presentation described in Item 8. Financial Statements and Supplementary Data – Note 2 – Summary of Significant Accounting Policies and Note 24 – Segment Data and Related Information, for our product categories that meet the definition of reportable segments, for all periods presented. Royalty revenue from license arrangements, and products and services that do not fit within our definitions of skin care, makeup, fragrance and hair care have been included in the “other” category.

[[GREPCENT_TABLE]]
[["","","Year Ended June 30,"],["(In millions)","","2025","","2024","","2023"],["NET SALES"],["By Product Category:"],["Skin Care","","$","6,962","","","$","7,908","","","$","8,249"],["Makeup","","4,205","","","4,470","","","4,532"],["Fragrance","","2,491","","","2,487","","","2,451"],["Hair Care","","565","","","629","","","652"],["Other","","100","","","115","","","53"],["","","14,323","","","15,609","","","15,937"],["Returns associated with restructuring and other activities","","3","","","(1)","","","(27)"],["Net sales","","$","14,326","","","$","15,608","","","$","15,910"],["By Geographic Region(1):"],["The Americas","","$","4,411","","","$","4,581","","","$","4,518"],["Europe, the Middle East & Africa","","5,375","","","6,140","","","6,225"],["Asia/Pacific","","4,537","","","4,888","","","5,194"],["","","14,323","","","15,609","","","15,937"],["Returns associated with restructuring and other activities","","3","","","(1)","","","(27)"],["Net sales","","$","14,326","","","$","15,608","","","$","15,910"],["OPERATING (LOSS) INCOME"],["By Product Category:"],["Skin Care","","$","574","","","$","735","","","$","1,277"],["Makeup","","(441)","","","93","","","(21)"],["Fragrance","","(378)","","","265","","","370"],["Hair Care","","(41)","","","(52)","","","(36)"],["Other","","(13)","","","53","","","4"],["","","(299)","","","1,094","","","1,594"],["Charges associated with restructuring and other activities","","(486)","","","(124)","","","(85)"],["Operating (loss) income","","$","(785)","","","$","970","","","$","1,509"],["By Geographic Region(1):"],["The Americas","","$","(918)","","","$","34","","","$","(73)"],["Europe, the Middle East & Africa","","610","","","836","","","843"],["Asia/Pacific","","9","","","224","","","824"],["","","(299)","","","1,094","","","1,594"],["Charges associated with restructuring and other activities","","(486)","","","(124)","","","(85)"],["Operating (loss) income","","$","(785)","","","$","970","","","$","1,509"]]
[[/GREPCENT_TABLE]]

(1)The net sales from the Company’s travel retail business are included in the Europe, the Middle East & Africa region, with the exception of net sales of Dr.Jart+ in the travel retail channel that are reflected in Korea in the Asia/Pacific region. Operating income attributable to the travel retail sales included in Europe, the Middle East & Africa is included in that region and in The Americas. This is primarily due to certain capabilities related to the travel retail business that are centralized in The Americas region and, as such, a component of the operating income generated by this business is transferred to The Americas through an intercompany royalty.

30

Table of Contents

Period-over-period changes in our net sales are generally attributable to the impacts from (i) pricing on our base portfolio, including changes in mix and those due to strategic pricing actions, (ii) volume, including changes driven by the impact of new product innovation, (iii) acquisitions and/or divestitures, and/or (iv) foreign currency translation. The percentages disclosed for these impacts are calculated on an individual basis.

The net sales impact from pricing consists of changes in list prices, due to strategic pricing actions, and mix shifts within and among product categories, geographic regions, brands and distribution channels. The prices at which we sell our products vary by brand, distribution channel (e.g., wholesale or direct-to-consumer) and may also vary by country. Our brands and products cover a broad array of pricing tiers. Prices of skin care and fragrance products are typically higher than makeup and hair care products.

New product innovation includes the introduction of new products, as well as changes related to existing products or markets where they are sold, including reformulations, regional expansion, repackaging and sets. A product is considered "new innovation" for the twelve-month period following the initial shipment date. Our innovation is often launched at different price points than existing products and value derived from innovation may vary from year to year. We continually introduce new products, support new and established products through advertising, merchandising and sampling and phase out existing products that no longer meet the needs of our consumers or our objectives. The economics of developing, producing, launching, supporting and discontinuing products impact our sales and operating performance each period. The introduction of new products often has some cannibalizing effect on sales of existing products, which we take into account in our business planning. The impact of new product introductions, including timing compared to introductions in prior periods, also affects our results.

Non-GAAP Financial Measures

We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period to period helps investors and others compare operating performance between periods. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. See Reconciliations of Non-GAAP Financial Measures beginning on page 47 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.

We operate on a global basis, with the majority of our net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, we present certain net sales, operating results, provision for income taxes and diluted net (loss) earnings per common share information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of our underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current-period results using prior year monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.

Overview

We are a leader in prestige beauty, which combines the repeat purchase and relative affordability of consumer goods with high quality products and services. Within prestige beauty, we are diversified by product category, geography, brand, product sub-category, channel, consumer segment and price point. We also leverage consumer analytics and insights across our brand portfolio to grow sales and pursue profitable opportunities. These analytics and insights, combined with our creativity, also inform our innovation to provide a broad, locally-relevant and inclusive range of prestige products with the aim of competing effectively for a greater share of a consumer's beauty routine.

Our global distribution capability and operations allow us to focus on targeted expanded consumer reach wherever consumer demographics and trends are attractive. Our regional organizations, and the expertise of our people there, enable our brands to be more locally and culturally relevant in both product assortment and communications. We are continually evolving the way we connect with our consumers in stores, online and where they travel, including by expanding our digital and social media presence and the engagement of global and local influencers to amplify brand or product stories. We tailor implementation of our strategy by market to drive consumer engagement, recruitment and loyalty. We strive to strengthen our presence in large, image-building core markets, while broadening our presence in emerging markets.

31

Table of Contents

We approach distribution strategically by product category and location and seek to optimize distribution by matching our brands with appropriate opportunities while seeking to maintain high productivity per door. We are expanding our brands' locations as we continue to seek high-growth opportunities to reach new consumers in online, freestanding stores, specialty-multi and travel retail, which we believe will be higher growth channels in the long term. We also focus on brand-building retail activities, technology-driven activations and omnichannel capabilities that enhance the shopping experience for consumers.

Outlook

We have experienced challenges within ou

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/EL/mda/fy2025/
All MD&A years: /company/EL/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/EL/mda/fy2024/): filed 2024-08-19; accession 0001001250-24-000116 (https://www.sec.gov/Archives/edgar/data/1001250/000100125024000116/el-20240630.htm)
- [FY 2023 MD&A](/company/EL/mda/fy2023/): filed 2023-08-18; accession 0001001250-23-000112 (https://www.sec.gov/Archives/edgar/data/1001250/000100125023000112/el-20230630.htm)
- [FY 2022 MD&A](/company/EL/mda/fy2022/): filed 2022-08-24; accession 0001001250-22-000122 (https://www.sec.gov/Archives/edgar/data/1001250/000100125022000122/el-20220630.htm)
- [FY 2021 MD&A](/company/EL/mda/fy2021/): filed 2021-08-27; accession 0001001250-21-000127 (https://www.sec.gov/Archives/edgar/data/1001250/000100125021000127/el-20210630.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 2844 Perfumes, Cosmetics & Other Toilet Preparations) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm

Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/EL.md · JSON record: /company/EL.json · verified financials: /company/EL/financials.json / /company/EL/financials.csv · machine TOC for the whole site: /llms.txt